Literature DB >> 12857662

Research advances in the understanding and treatment of addiction.

Charles P O'Brien1.   

Abstract

The likelihood of developing an addictive disorder is a function of multiple simultaneous, pharmacologic, genetic, and environmental variables, such as the pharmacology of the drug, the route of administration, the personality of the individual, and the availability of the drug. There is increasing evidence that long-lasting changes in the brain result from the progression of casual user to addict. Moreover, the course of the progression of addiction is similar to that of other chronic diseases. In this paper, strategies for effective treatment of addiction, including long-term relapse management and new pharmacological therapies such as naltrexone and acamprosate, are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857662

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  29 in total

1.  D-Serine facilitates the effectiveness of extinction to reduce drug-primed reinstatement of cocaine-induced conditioned place preference.

Authors:  Sherri Hammond; Claire M Seymour; Ashley Burger; John J Wagner
Journal:  Neuropharmacology       Date:  2012-06-20       Impact factor: 5.250

2.  Region-specific involvement of AMPA/Kainate receptors in Fos protein expression induced by cocaine-conditioned cues.

Authors:  Arturo R Zavala; Jenny R Browning; Erin D Dickey; Sudipta Biswas; Janet L Neisewander
Journal:  Eur Neuropsychopharmacol       Date:  2008-06-06       Impact factor: 4.600

3.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

4.  Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.

Authors:  Hidetaka Yamada; Mahendra Bishnoi; Kim F M Keijzers; Irma A van Tuijl; Elysia Small; Hina P Shah; Rayna M Bauzo; Firas H Kobeissy; Sreedharan N Sabarinath; Hartmut Derendorf; Adrie W Bruijnzeel
Journal:  Pharmacol Biochem Behav       Date:  2010-03-06       Impact factor: 3.533

5.  Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.

Authors:  Amber L LaCrosse; Sinead M O'Donovan; Marian T Sepulveda-Orengo; Robert E McCullumsmith; Kathryn J Reissner; Marek Schwendt; Lori A Knackstedt
Journal:  J Neurosci       Date:  2017-05-11       Impact factor: 6.167

Review 6.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

7.  Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats.

Authors:  George Zislis; Tina V Desai; Melissa Prado; Hina P Shah; Adrie W Bruijnzeel
Journal:  Neuropharmacology       Date:  2007-09-23       Impact factor: 5.250

Review 8.  Treatment of tobacco dependence: integrating recent progress into practice.

Authors:  Bernard Le Foll; Tony P George
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

9.  Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.

Authors:  Catherine A Marcinkiewcz; Melissa M Prado; Shani K Isaac; Alex Marshall; Daria Rylkova; Adrie W Bruijnzeel
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

Review 10.  The neurobiology of cocaine addiction.

Authors:  Eric J Nestler
Journal:  Sci Pract Perspect       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.